α2-Adrenergic agonists protect against radiocontrast-induced nephropathy in mice

American Journal of Physiology - Renal Physiology

Volumn 295, Issue 3, 2008, Pages

  Billings IV, F T ^a   Chen, Sean W C ^a   Kim, Mihwa ^a   Sang, Won Park ^a   Song, Joseph H ^a   Wang, Shuang ^a   Herman, Joseph ^b   D'Agati, Vivette ^a   Lee, H Thomas ^a,c  

^a Columbia University ^*  (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Acute renal failure; Clonidine; Dexmedetomidine; HK 2 cells; Iohexol; Medullary ischemia; Yohimbine

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; CREATININE; DEXMEDETOMIDINE; IOHEXOL; SODIUM CHLORIDE; YOHIMBINE; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CONTRAST MEDIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD PRESSURE; C57BL 6 MOUSE; CELL PROTECTION; CELL TYPE; CELL VACUOLE; CELL VIABILITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG INDUCED DISEASE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; KIDNEY BLOOD FLOW; KIDNEY CORTEX; KIDNEY DISEASE; KIDNEY MEDULLA; KIDNEY PERFUSION; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE NECROSIS; LUNG ALVEOLUS CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOCONTRAST NEPHROPATHY; RAT; ANIMAL; BLOOD; C57BL MOUSE; CELL LINE; CHEMICALLY INDUCED DISORDER; KIDNEY CIRCULATION; VASCULARIZATION;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; CELL LINE; CLONIDINE; CONTRAST MEDIA; DEXMEDETOMIDINE; IOHEXOL; KIDNEY DISEASES; KIDNEY MEDULLA; MALE; MICE; MICE, INBRED C57BL; RENAL CIRCULATION;

EID: 54449094512     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.90244.2008     Document Type: Article

References (33)

1. Agmon Y, Peleg H, Greenfeld Z, Rosen S, Brezis M. Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat. J Clin Invest 94: 1069-1075, 1994.
2. Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348: 491-499, 2003.
3. Barrett BJ, Parfrey PS. Clinical practice: preventing nephropathy induced by contrast medium. N Engl J Med 354: 379-386, 2006.
4. Beaufils H, Idee JM, Berthommier C, Balut C, Bourbouze R, Nimier K, Chicandre-Jouanneau C, Bonnemain B. Iobitridol, a new nonionic low-osmolality contrast agent, and iohexol. Impact on renal histology in the rat. Invest Radiol 30: 33-39, 1995.
5. Dyck JB, Maze M, Haack C, Vuorilehto L, Shafer SL. The pharmacokinetics and hemodynamic effects of intravenous and intramuscular dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology 78: 813-820, 1993.
6. Erley CM, Heyne N, Burgert K, Langanke J, Risler T, Osswald H. Prevention of radiocontrast-induced nephropathy by adenosine antagonists in rats with chronic nitric oxide deficiency. J Am Soc Nephrol 8: 1125-1132, 1997.
7. Freeman RV, O'Donnell M, Share D, Meengs WL, Kline-Rogers E, Clark VL, DeFranco AC, Eagle KA, McGinnity JG, Patel K, Maxwell-Eward A, Bondie D, Moscucci M. Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 90: 1068-1073, 2002.
8. Haller C, Hizoh I. The cytotoxicity of iodinated radiocontrast agents on renal cells in vitro. Invest Radiol 39: 149-154, 2004.
9. Hardiek K, Katholi RE, Ramkumar V, Deitrick C. Proximal tubule cell response to radiographic contrast media. Am J Physiol Renal Physiol 280: F61-F70, 2001.
10. 2-adrenoreceptor activation. J Physiol 563: 541-555, 2005.
11. Heinegard D, Tiderstrom G. Determination of serum creatinine by a direct colorimetric method. Clin Chim Acta 43: 305-310, 1973.
12. Heyman SN, Rosenberger C, Rosen S. Regional alterations in renal haemodynamics and oxygenation: a role in contrast medium-induced nephropathy. Nephrol Dial Transplant 20 Suppl I: I6 -I11, 2005.
13. Hizoh I, Haller C. Radiocontrast-induced renal tubular cell apoptosis: hypertonic versus oxidative stress. Invest Radiol 37: 428-434, 2002.
14. 2B-Adrenergic receptors: immunolocalization and regulation by potassium depletion in rat kidney. Am J Physiol Renal Fluid Electrolyte Physiol 270: F1015-F1026, 1996.
15. Kozak LJ, DeFrances CJ, Hall MJ. National hospital discharge survey: 2004 annual summary with detailed diagnosis and procedure data. Vital Health Stat 162: 1-209, 2006.
16. Lee HT, Jan M, Bae SC, Joo JD, Goubaeva FR, Yang J, Kim M. A1 adenosine receptor knockout mice are protected against acute radiocontrast nephropathy in vivo. Am J Physiol Renal Physiol 290: F1367-F1375, 2006.
17. Lee JI, Su F, Shi H, Zuppa AF. Sensitive and specific liquid chromatography-tandem mass spectrometric method for the quantitation of dexmedetomidine in pediatric plasma. J Chromatogr B Analyt Technol Biomed Life Sci 852: 195-201, 2007.
18. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA 275: 1489-1494, 1996.
19. Lowenthal DT, Matzek KM, MacGregor TR. Clinical pharmacokinetics of clonidine. Clin Pharmacokinet 14: 287-310, 1988.
20. 2a-adrenergic receptor subtype. Science 273: 801-803, 1996.
21. Manske CL, Sprafka JM, Strony JT, Wang Y. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 89: 615-620, 1990.
22. Mueller C, Buerkle G, Buettner HJ, Petersen J, Perruchoud AP, Eriksson U, Marsch S, Roskamm H. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 162: 329-336, 2002.
23. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 39: 930-936, 2002.
24. 2 during water diuresis as evaluated by blood oxygenation level-dependent magnetic resonance imaging: effects of aging and cyclooxygenase inhibition. Kidney Int 55: 294-298, 1999.
25. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, Singh M, Bell MR, Barsness GW, Mathew V, Garratt KN, Holmes DR Jr. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105: 2259-2264, 2002.
26. Roman RJ, Cowley AW Jr, Lechene C. Water diuretic and natriuretic effect of clonidine in the rat. J Pharmacol Exp Ther 211: 385-393, 1979.
27. Roman RJ, Smits C. Laser-Doppler determination of papillary blood flow in young and adult rats. Am J Physiol Renal Fluid Electrolyte Physiol 251: F115-F124, 1986.
28. Scheinin H, Karhuvaara S, Olkkola KT, Kallio A, Anttila M, Vuorilehto L, Scheinin M. Pharmacodynamics and pharmacokinetics of intramuscular dexmedetomidine. Clin Pharmacol Ther 52: 537-546, 1992.
29. Skelding KA, Best PJ, Bartholomew BA, Lennon RJ, O'Neill WW, Rihal CS. Validation of a predictive risk score for radiocontrast-induced nephropathy following percutaneous coronary intervention. J Invasive Cardiol 19: 229-233, 2007.
30. Trivedi HS, Moore H, Nasr S, Aggarwal K, Agrawal A, Goel P, Hewett J. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 93: C29-C34, 2003.
31. Tumlin J, Stacul F, Adam A, Becker CR, Davidson C, Lameire N, McCullough PA. Pathophysiology of contrast-induced nephropathy. Am J Cardiol 98: 14K-20K, 2006.
32. Wood M. Drugs and the sympathetic nervous system. In: Drugs and Anesthesia: Pharmacology for Anesthesiologists, edited by Wood M, Wood A. Baltimore, MD: Williams & Wilkins, 1990, p. 375-405.
33. Zager RA, Johnson AC, Hanson SY. Radiographic contrast media-induced tubular injury: evaluation of oxidant stress and plasma membrane integrity. Kidney Int 64: 128-139, 2003.